Join Target ALS as they team with Spartan to raise ALS awareness and funds for medical research during this difficult time. Learn the details, sign up, and get started at www.toughestchallenge.com. Written by Josh Hall Life has changed in our new COVID-19...
Earlier this month, Target ALS and The Association for Frontotemporal Degeneration (AFTD) announced six teams who will receive a portion of $5 million in funding for projects targeting the discovery of treatments and biomarkers* for ALS and FTD. Though FTD represents...
As the world begins the restoration project that is life after COVID-19, a major challenge will be establishing means to carefully return to daily activities. For Ludo Van Den Bosch of the Belgium-based Flanders Institute for Biotechnology (VIB), that means proceeding...
The ALS Association reports that at least 16,000 people in the U.S. have the disease at any given time, and more than 5,000 Americans are diagnosed each year. Anecdotal evidence shows that upon diagnosis, most of those patients and their family members immediately...
When Target ALS and The Association for Frontotemporal Degeneration (AFTD) put out a funding call late last year, the goal was to identify projects that the two organizations could jointly support. The scope of the projects involved targeting the discovery of...
